dioxygen
Overview
Dioxygen (O₂) is a diatomic molecule composed of two bonded oxygen atoms and represents the primary electron acceptor in aerobic metabolism across most living organisms. In normal physiology, dioxygen is essential for cellular respiration, serving as the terminal electron acceptor in the mitochondrial electron transport chain and enabling efficient adenosine triphosphate (ATP) production. However, in pathological conditions such as solid tumors, hypoxic microenvironments develop due to insufficient vascularization and high metabolic demand, creating regions of inadequate oxygen availability. These hypoxic regions have emerged as a significant barrier to therapeutic efficacy, as many treatment modalities—including photodynamic therapy, immunotherapy, and ferroptosis-based approaches—depend on adequate oxygen tension for optimal function.
The biomedical significance of oxygen has expanded in recent years with the development of engineered platforms designed to generate, deliver, or sense molecular oxygen at the site of disease. These approaches recognize that traditional systemic oxygen supplementation strategies face limitations in achieving precise spatiotemporal control and adequate penetration into heterogeneous tissue microenvironments. As a result, local oxygen generation and delivery have become focal points in developing next-generation therapeutics for cancer, wound healing, and inflammatory conditions.
Recent Publications Summary
Recent publications have mainly examined dioxygen as a functional component in oxygen-delivery, oxygen-generating, or oxygen-enriching strategies designed to improve therapeutic performance in hypoxic or oxygen-dependent disease settings. In a review of emerging nanoplatforms against tumor hypoxia, dioxygen was discussed in the context of three broad design strategies: exogenous oxygen delivery, endogenous oxygen generation, and metabolic oxygen conservation, all intended to remodel the tumor microenvironment and enhance multimodal combination therapies 42325397Jun. In a separate laryngeal cancer study, an oxygen-embedded fused-ring organic semiconductor was incorporated into nanoparticles for near-infrared-triggered multimodal phototherapy, where the oxygen-containing design supported strong photothermal conversion and production of reactive oxygen species through synergistic Type I and Type II photodynamic pathways 42587459Aug.
Several studies leveraged dioxygen to improve photodynamic effects by increasing local oxygen availability for reactive oxygen species generation. Perfluoroalkylated porphyrin nanomicelles formed a fluorocarbon microphase that enriched and delivered O2, markedly enhancing photosensitizing activity for singlet oxygen generation and improving in vivo tumor growth inhibition relative to a fluorine-free counterpart 42084067May. Likewise, the oxygen-embedded nanoparticle system for laryngeal cancer generated multiple reactive oxygen species, including •OH, O2-, and 1O2, and produced substantially higher ROS levels in vitro than monotherapies, with strong antitumor efficacy in vivo after NIR irradiation 42587459Aug.
Dioxygen was also modeled or supplied in non-oncologic contexts. A mathematical model of peritoneal dialysis incorporated O2 transport across central circulation and tissues alongside CO2 and bicarbonate/lactate dynamics to predict acid-base changes during dialysis sessions 42401598Jul. In diabetic wound repair, a cascade nanozyme hydrogel was designed to release both nitric oxide and O2, with catalase-like decomposition of endogenous hydrogen peroxide supporting sustained oxygen generation; this combined delivery improved antibacterial activity, promoted macrophage polarization toward the M2 phenotype, and enhanced endothelial cell proliferation during wound healing 41864579Mar.
In radiation biology, oxygen beams were evaluated as part of minibeam radiation therapy alongside helium and carbon beams. Synchrotron-based infrared microspectroscopy showed biomolecular alterations in glioma cell lines after oxygen minibeam radiation therapy, including changes in DNA/RNA-related spectral regions and phosphodiester backbone signatures, indicating that oxygen-ion irradiation produced measurable cellular responses comparable to the other beam types 42329645Jun.
What Changes, What Holds
1. Oxygen is being positioned as an engineering component of hypoxia therapy rather than only a physiologic gas
NEW DIRECTION Nanoplatforms now use dioxygen in three roles: delivered from outside, generated inside, or conserved metabolically, all to remodel the tumor microenvironment and support combination therapy 42325397Jun. The oxygen-embedded laryngeal cancer system extends that same direction by treating oxygen as part of the material design that improves photothermal conversion and ROS formation 42587459Aug. This does not overturn the baseline, but it broadens oxygen from a required metabolic substrate to an active therapeutic design element.
2. Local oxygen enrichment remains a straightforward way to strengthen oxygen-dependent photodynamic therapy
REINFORCES Perfluoroalkylated porphyrin nanomicelles and the oxygen-embedded nanoparticle system both do what the baseline already anticipates: they raise local oxygen availability so reactive oxygen species generation is more effective under irradiation 42084067May42587459Aug. The new work sharpens the point that oxygen loading, retention, or in situ enrichment can materially improve antitumor photodynamic performance, but it does not change the underlying account that oxygen tension is a limiting factor for these therapies.
3. Oxygen is now being modeled and delivered in noncancer applications as part of broader tissue-level control
NEW DIRECTION A peritoneal dialysis transport model treats O2 as one variable in acid-base and solute dynamics, which is a methodological extension of how oxygen is represented in physiology rather than a challenge to the baseline 42401598Jul. More importantly, the wound-healing hydrogel uses O2 generation together with nitric oxide to support antibacterial activity, macrophage polarization, and endothelial proliferation 41864579Mar. That adds a regenerative-medicine role not covered in the overview, showing oxygen can be therapeutic outside tumor hypoxia.
4. Oxygen-ion irradiation produces measurable cellular effects that fit within radiation-response studies
METHOD Synchrotron infrared microspectroscopy was used to read biomolecular changes after oxygen minibeam radiation therapy, giving a measurement framework for comparing beam types in glioma cells 42329645Jun. The paragraph changes how oxygen-beam effects are studied, not what is known about dioxygen itself. It neither contradicts nor materially extends the baseline’s account of oxygen as a requirement for therapy; instead, it supplies an analytical tool for assessing cellular responses to oxygen-ion exposure.
Overview update candidates: oxygen as an active design element in hypoxia-targeted nanoplatforms; therapeutic oxygen generation for diabetic wound repair; oxygen-ion minibeam response measurement as a study method.
dioxygen
Background Contexts
In the literature, the biological baseline, pathological conditions, or disease models commonly surrounding dioxygen are described as follows:
- hypoxia (Biological Process) — 6 papers: PMIDs 42518188, 42470667, 42381358, 42332425, etc.
- photochemotherapy (Biological Process) — 3 papers: PMIDs 42518188, 42470667, 42148594
- immunosuppressive tumor microenvironments (Biological Process) — 2 papers: PMIDs 42328680, 42325397
- reactive oxygen species (Chemical) — 2 papers: PMIDs 42349732, 42233718
- solid tumors (Disease) — 2 papers: PMIDs 42518188, 42381358
- tumor microenvironment (Biological Process) — 2 papers: PMIDs 42470667, 42148957
- Amphiphilic porphyrin nanomicelles (Technology) — 1 paper: PMIDs 42084067
- angiogenesis (Biological Process) — 1 paper: PMIDs 42233718
- Anti-angiogenic agents (Therapy) — 1 paper: PMIDs 42425237
- autoimmune disease (Disease) — 1 paper: PMIDs 42383406
- Bacterial infection (Disease) — 1 paper: PMIDs 42349732
- bionic black phosphorus quantum dot cluster nanozyme (Technology) — 1 paper: PMIDs 41763117
Methodologies & Technologies Used
Researchers utilize the following experimental methods, imaging platforms, computational models, or biological reagents to study dioxygen:
- Glucose oxidase (GOD) (Protein) — 3 papers: PMIDs 42518188, 42233718, 41759381
- manganese dioxide (Chemical) — 3 papers: PMIDs 42518188, 42470667, 42148594
- carbon quantum dots (Other) — 2 papers: PMIDs 42383406, 42295119
- hydrogen peroxide (Chemical) — 2 papers: PMIDs 42518188, 42455178
- NIR irradiation (Technology) — 2 papers: PMIDs 42587459, 41864579
- sulfur (Chemical) — 2 papers: PMIDs 42383406, 42381358
- 2-DG (Chemical) — 1 paper: PMIDs 42148957
- 4T1 (Cell Line) — 1 paper: PMIDs 42148957
- anti-PD-L1 single-chain antibodies (Protein) — 1 paper: PMIDs 42306934
- aPD-L1 (Therapy) — 1 paper: PMIDs 41763117
- Atomic engineering (Technology) — 1 paper: PMIDs 42381358
- AuPtCu (Other) — 1 paper: PMIDs 42148957
Molecular Interventions & Targets
The primary molecular pathways, regulatory genes, enzymes, or therapeutic agents actively targeted and manipulated in relation to dioxygen include:
- hydrogen peroxide (Chemical) — 2 papers: PMIDs 42332425, 42306934
- (E)-chlorogenic acid (Chemical) — 1 paper: PMIDs 42300531
- ARG2 (Protein) — 1 paper: PMIDs 42332425
- bicarbonate (Chemical) — 1 paper: PMIDs 42401598
- bimetallic MOF (Other) — 1 paper: PMIDs 41763117
- calcium peroxide (Chemical) — 1 paper: PMIDs 42328680
- carbon (Chemical) — 1 paper: PMIDs 42329645
- carbon dioxide (Chemical) — 1 paper: PMIDs 42401598
- Cu2O@Pt NPs (Chemical) — 1 paper: PMIDs 41679436
- Cu2O@Pt-LOx@Lpo nanoparticles (CPLL NPs) (Chemical) — 1 paper: PMIDs 41679436
- DL-lactic acid (Chemical) — 1 paper: PMIDs 42401598
- DNAI1 (Gene) — 1 paper: PMIDs 41935025
Observed Outcomes & Phenotypes
The phenotypic changes, physiological endpoints, or clinical metrics observed and measured in connection with dioxygen include:
- reactive oxygen species (Chemical) — 6 papers: PMIDs 42587459, 42518188, 42470667, 42349732, etc.
- hydrogen peroxide (Chemical) — 5 papers: PMIDs 42470667, 42328680, 42233718, 42148957, etc.
- immunogenic cell death (Biological Process) — 4 papers: PMIDs 42470667, 42455178, 42332425, 42295119
- hypoxia (Biological Process) — 3 papers: PMIDs 42470667, 42233718, 42148957
- 2'-deoxyadenosine triphosphate (Biological Process) — 2 papers: PMIDs 42295119, 42148957
- dendritic cell maturation (Biological Process) — 2 papers: PMIDs 42455178, 42332425
- HO• (Chemical) — 2 papers: PMIDs 41763117, 41759381
- hydroxyl radical (Chemical) — 2 papers: PMIDs 42587459, 42148957
- intersystem crossing (Biological Process) — 2 papers: PMIDs 42587459, 42132802
- Nrf-2-SLC7A11-GSH pathway (Pathway) — 2 papers: PMIDs 42148957, 41763117
- proinflammatory cytokine (Biological Process) — 2 papers: PMIDs 42295119, 41763117
- sensitivity (Clinical Metric) — 2 papers: PMIDs 42383406, 42329645
General Takeaways & Clinical Potentials
The high-level concepts, clinical translations, and overarching conclusions proposed in the research surrounding dioxygen are summarized below:
- CD4+ T cells and antitumor immunity (Biological Process) — 2 papers: PMIDs 42470667, 42425237
- acid–base homeostasis (Biological Process) — 1 paper: PMIDs 42401598
- anti-angiogenesis (Biological Process) — 1 paper: PMIDs 42148594
- anti-metastasis (Biological Process) — 1 paper: PMIDs 42148594
- anti-tumor and anti-inflammatory activities (Biological Process) — 1 paper: PMIDs 41763117
- antibacterial-promoting healing (Biological Process) — 1 paper: PMIDs 41759381
- buffer composition (Other) — 1 paper: PMIDs 42401598
- cancer immunotherapy (Biological Process) — 1 paper: PMIDs 42328680
- cancer-associated fibroblast (Cellular Component) — 1 paper: PMIDs 41679436
- cervix uterine cancer (Disease) — 1 paper: PMIDs 42518188
- chemo-optical biosensors (Other) — 1 paper: PMIDs 42390183
- clinically viable strategy for recalibrating age-related skeletal disorders (Other) — 1 paper: PMIDs 41864579
